by Marina Festinese | Dec 5, 2022 | News
Belgrade | 8th-9th November 2021 Visit the Congress web page
by Marina Festinese | Sep 15, 2022 | Executive board members
Coming soon!
by Marina Festinese | Mar 26, 2019 | News, Newsletter
A periodical mailing list on what’s going on in the Society. Inputs on initiatives, events and hot topics will reach you and will keep you updated on ESPT world as well as on pharmacogenomics and personalised therapy in general.You can find here the Newsletters...
by Marina Festinese | Mar 13, 2019 | News
Drug Metabolism and Personalized Therapy (DMPT). We would like to invite all members of ESPT to submit their scientific work – Reviews, Research Articles, Short Communications, Case Reports, Letters to the Editor – to DMPT. Publication of color figures is free of...
by wp_3863239 | Feb 9, 2019 | Executive board members
Director of Research at INSERM Research Unit in Nancy, France: INSERM UMR U1122; IGE-PCV (Interactions Géne-Environement en Physiopathologie Cardio-Vasculaire) at the University of Lorraine and of a BRC (Biological Resources Center), the BRC IGE-PCV. Sofia Siest’s...
by wp_3863239 | Feb 9, 2019 | Executive board members
UCB Biopharma Genetics Lead, Director Associate, Professor Associate Genetics, Data & Translational Sciences, Early Solutions Leading expert of Pharmacogenetics in drug discovery. Identification and validation of genetically supported drug targets focusing on...
by wp_3863239 | Feb 9, 2019 | Executive board members
University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia Full Professor of Clinical Biochemistry, PI in genetics of complex disorders Full professor of Clinical Biochemistry, coordinator of PhD program of Clinical Biochemistry at University of Ljubljana and...
by wp_3863239 | Feb 9, 2019 | Executive board members
Thermo Fisher Scientific Associate Director, Business Development Genetic Sciences Division Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $24 billion and approximately 70,000 employees globally. Our...
by wp_3863239 | Feb 9, 2019 | Executive board members
Dr. Adrián LLerena Ph.D. is the Director of the Clinical Research Center in the University Hospital in Badajoz Spain. He is also professor of Pharmacology and Clinical Pharmacology in the Medical School of the University of Extremadura, between 1989-1993 he did his...
by wp_3863239 | Feb 9, 2019 | Executive board members
University of Kiel, Germany Full Professor of Pharmacology Graduation in biochemistry and in medicine, Free University Berlin. Dr. rer. nat. (PhD) in 1989, specialization in clinical pharmacology at Charité Berlin (1998), Dr. med. (MD) in 1999. Habilitation in...
